0

524314

GUJTERC

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

GUJARAT TERCE LABORATORIES LTD Share Price Today

Investment Returns

Over 1 Month -1.67% Over 3 Months -10.46% Over 6 Months -29.13% Over 1 Year -36.42%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

GUJARAT TERCE LABORATORIES LTD fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 26.50
  • P/E Ratio (TTM) 12.06
  • Beta 0.56
  • Book Value / share 12.48
  • Return on equity 0.00%
  • EPS (TTM) 3.20
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.10
info icon alternate text

GUJARAT TERCE LABORATORIES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 11.40
Operating Expense 10.81
Net Profit 0.10
Net Profit Margin (%) 0.87
Earnings Per Share (EPS) 0.13
EBITDA 0.36
Effective Tax Rate (%) 50.00
Particulars DEC 2025 (Values in Cr)
Revenue 12.29
Operating Expense 11.29
Net Profit 0.76
Net Profit Margin (%) 6.18
Earnings Per Share (EPS) 0.95
EBITDA 1.27
Effective Tax Rate (%) 32.74
Particulars SEP 2025 (Values in Cr)
Revenue 12.93
Operating Expense 11.20
Net Profit 1.40
Net Profit Margin (%) 10.82
Earnings Per Share (EPS) 1.89
EBITDA 1.95
Effective Tax Rate (%) 21.34
Particulars JUN 2025 (Values in Cr)
Revenue 10.85
Operating Expense 11.02
Net Profit -0.04
Net Profit Margin (%) -0.36
Earnings Per Share (EPS) -0.06
EBITDA 0.08
Effective Tax Rate (%) 42.85
Particulars MAR 2025 (Values in Cr)
Revenue 12.32
Operating Expense 11.44
Net Profit -3.39
Net Profit Margin (%) -27.51
Earnings Per Share (EPS) -4.57
EBITDA 1.14
Effective Tax Rate (%) 449.48
Particulars MAR 2026 (Values in Cr)
Revenue 47.47
Operating Expense 44.33
Net Profit 2.20
Net Profit Margin (%) 4.63
Earnings Per Share (EPS) 2.92
EBITDA 3.63
Effective Tax Rate (%) 27.39
Particulars MAR 2025 (Values in Cr)
Revenue 50.20
Operating Expense 47.12
Net Profit -0.98
Net Profit Margin (%) -1.95
Earnings Per Share (EPS) -1.31
EBITDA 4.19
Effective Tax Rate (%) 128.90
Particulars MAR 2024 (Values in Cr)
Revenue 47.97
Operating Expense 47.76
Net Profit 0.24
Net Profit Margin (%) 0.50
Earnings Per Share (EPS) 0.33
EBITDA 1.59
Effective Tax Rate (%) 55.55
Particulars MAR 2023 (Values in Cr)
Revenue 46.78
Operating Expense 50.03
Net Profit -1.67
Net Profit Margin (%) -3.56
Earnings Per Share (EPS) -2.25
EBITDA -1.81
Effective Tax Rate (%) 42.21
Particulars MAR 2022 (Values in Cr)
Revenue 40.13
Operating Expense 39.69
Net Profit 0.87
Net Profit Margin (%) 2.16
Earnings Per Share (EPS) 1.18
EBITDA 1.43
Effective Tax Rate (%) -17.33
Particulars MAR 2025 (Values in Cr)
Book Value / Share 8.26
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.35
EBITDA Margin 8.37
Particulars MAR 2024 (Values in Cr)
Book Value / Share 9.58
ROE % 2.96
ROCE % 7.17
Total Debt to Total Equity 0.80
EBITDA Margin 3.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 9.25
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.91
EBITDA Margin -3.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.50
ROE % 10.24
ROCE % 6.74
Total Debt to Total Equity 0.70
EBITDA Margin 3.54
Particulars MAR 2021 (Values in Cr)
Book Value / Share 10.33
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.39
EBITDA Margin -7.82
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.77
Total Assets 22.82
Total Liabilities 22.82
Total Equity 6.47
Share Outstanding 0
Price to Book Ratio 7.40
Return on Assets (%) -4.28
Return on Capital (%) -13.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 23.27
Total Liabilities 23.27
Total Equity 7.10
Share Outstanding 0
Price to Book Ratio 5.53
Return on Assets (%) 1.04
Return on Capital (%) 2.22
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.02
Total Assets 28.52
Total Liabilities 28.52
Total Equity 6.86
Share Outstanding 0
Price to Book Ratio 1.80
Return on Assets (%) -5.85
Return on Capital (%) -11.83
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 27.39
Total Liabilities 27.39
Total Equity 8.53
Share Outstanding 0
Price to Book Ratio 2.27
Return on Assets (%) 3.18
Return on Capital (%) 5.74
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.28
Total Assets 21.87
Total Liabilities 21.87
Total Equity 7.66
Share Outstanding 0
Price to Book Ratio 0.67
Return on Assets (%) -11.52
Return on Capital (%) -20.33
Particulars MAR 2025 (Values in Cr)
Net Income 3.39
Cash from Operations 3.14
Cash from Investing 0.45
Cash from Financing -2.82
Net change in Cash 0.68
Free Cash Flow 3.14
Particulars MAR 2024 (Values in Cr)
Net Income 0.54
Cash from Operations 2.59
Cash from Investing -0.45
Cash from Financing -4.08
Net change in Cash -1.93
Free Cash Flow 2.67
Particulars MAR 2023 (Values in Cr)
Net Income -2.89
Cash from Operations 0.06
Cash from Investing 0.61
Cash from Financing -0.12
Net change in Cash 0.52
Free Cash Flow 0.12
Particulars MAR 2022 (Values in Cr)
Net Income 0.74
Cash from Operations -0.34
Cash from Investing -0.86
Cash from Financing 1.53
Net change in Cash 0.22
Free Cash Flow 1.77
Particulars MAR 2021 (Values in Cr)
Net Income -2.52
Cash from Operations -0.01
Cash from Investing -0.42
Cash from Financing 1.83
Net change in Cash 1.24
Free Cash Flow 0.48
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LIMITED 338.20 14.92 2.44 995.36 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2332.85 41.07 17.42 39519.89 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTAJAN HEALTH LTD 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

GUJARAT TERCE LABORATORIES LTD shareholding pattern

Holding
59.97%
40.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

GUJARAT TERCE LABORATORIES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
34.05 -0.20 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 34.60
  • 26 Days 34.80
  • 10 Days 34.50
  • 50 Days 35.50
  • 12 Days 34.50
  • 100 Days 37.60
  • 20 Days 34.60
  • 200 Days 41.70
34.41 PIVOT
First Support 33.71 First Resistance 34.82 Second Support 33.30 Second Resistance 35.52 Third Support 32.60 Third Resistance 35.93
RSI 47.67 ADX 11.47 MACD -0.29 Williams % R -57.81 Commodity Channel Index (CCI) -27.90
Date 2026-06-19 Week 3038.00 Same Day 5668.00 Month 3200.00
1 Year 0.57 3 Year 0.23
Over 1 Month
-1.67% down
Over 1 Year
-36.42% down
Over 3 Months
-10.46% down
Over 3 Years
5.02% down
Over 6 Months
-29.13% down
Over 5 Years
29.82% down

GUJARAT TERCE LABORATORIES LTD Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Gujarat Terce Laboratories Ltd?

Answer Field

Gujarat Terce Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 34.05 as on Jun 22 2026 03:10 PM.

What is the Market Cap of Gujarat Terce Laboratories Ltd Share?

Answer Field

The market cap of Gujarat Terce Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 26.50 as on Jun 22 2026 03:10 PM.

What is the 52 Week High and Low of Gujarat Terce Laboratories Ltd?

Answer Field

The 52 Week High and Low of Gujarat Terce Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 59.78 and ₹ 29.00.

What is 1 year return for Gujarat Terce Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -36.42%.

What is the P/E Ratio of Gujarat Terce Laboratories Ltd Share?

Answer Field

As on Jun 22 2026 03:10 PM the price-to-earnings (PE) ratio for Gujarat Terce Laboratories Ltd share is 12.06.

What is the PB ratio of Gujarat Terce Laboratories Ltd Share?

Answer Field

As on Jun 22 2026 03:10 PM, the price-to-book (PB) ratio for Gujarat Terce Laboratories Ltd share is 12.48.

How to Buy Gujarat Terce Laboratories Ltd Share?

Answer Field

You can trade in Gujarat Terce Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gujarat Terce Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Gujarat Terce Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gujarat Terce Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|